The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis

被引:22
|
作者
Toya, Yosuke [1 ]
Chiba, Toshimi [1 ]
Mizutani, Tomomi [1 ]
Sato, Kunihiko [1 ]
Kasugai, Satoshi [1 ]
Matsuda, Nozomi [1 ]
Orikasa, Shunsuke [1 ]
Shibata, Sho [1 ]
Abiko, Yukito [1 ]
Akasaka, Risaburo [1 ]
Yokoyama, Naoki [1 ]
Oana, Shuhei [1 ]
Hirota, Shigeru [1 ]
Endo, Masaki [1 ]
Suzuki, Kazuyuki [1 ]
机构
[1] Iwate Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Morioka, Iwate 0208505, Japan
关键词
Ulcerative colitis; Granulocyte and monocyte adsorptive apheresis; GMA; Cytokine levels; Interleukin-10; INFLAMMATORY-BOWEL-DISEASE; REFRACTORY CROHNS-DISEASE; POLYMORPHONUCLEAR NEUTROPHILS; SELECTIVE LEUKOCYTAPHERESIS; INTESTINAL INFLAMMATION; INDUCIBLE PROTEIN-10; T-CELLS; ADACOLUMN; EFFICACY; THERAPY;
D O I
10.1016/j.cyto.2013.01.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Granulocyte and monocyte adsorptive apheresis (GMA) with an Adacolumn has been reported to be effective as induction therapy in ulcerative colitis (UC). However, the effects of GMA on serial changes in cytokine levels have not been well characterized. We therefore, investigated cytokine levels in UC patients before and after treatment with GMA. A total of 16 patients with active UC, 10 men, and six women, mean age, 42.6 years were included. Fourteen patients had total colitis and two patients had left-sided colitis. The study included nine patients with a chronic intermittent course, six with a chronic continuous course and one with a single episode. The duration of each GMA session was 60 min at a flow rate of 30 mL/min as per study protocol. Serum levels of 17 cytokines were determined simultaneously using a Bio-Plex suspension array system before and after treatment with GMA. Serum interleukin (IL)-10 and macrophage inflammatory protein-1 beta levels were increased significantly in UC patients after GMA treatment compared to pre-treatment levels (P < 0.05). In particular, GMA treatment caused a significant increase in serum IL-10 levels compared to pre-treatment in patients with total colitis or with a chronic intermittent UC course. In conclusion, this investigation showed that GMA was associated with a marked increase in serum level of the anti-inflammatory cytokine, IL-10. The rise in circulating IL-10 is interesting, and potentially a significant factor in the efficacy of GMA in patients with inflammatory bowel diseases. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [1] Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus
    Fukuchi, Takumi
    Nakase, Hiroshi
    Matsuura, Minoru
    Yoshino, Takuya
    Toyonaga, Takahiko
    Ohmori, Katsuyuki
    Ubukata, Satoshi
    Ueda, Aya
    Eguchi, Takaaki
    Yamashita, Hiroshi
    Ito, Dai
    Ashida, Kiyoshi
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (10) : 803 - 811
  • [2] Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis
    Andoh, A
    Tsujikawa, T
    Inatomi, O
    Deguchi, Y
    Hata, K
    Kitoh, K
    Sasaki, M
    Mitsuyama, K
    Fujiyama, Y
    THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (02) : 123 - 127
  • [3] Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis
    Yanagisawa, Kazuki
    Murakami, Minoru
    Kondo, Yuya
    Oguma, Shun
    Kobayashi, Shun
    Miyasaka, Hiroshi
    Shinohara, Tomoaki
    Tomori, Akihisa
    Nakano, Yui
    Furuhata, Shunichi
    Ikezoe, Masaya
    THERAPEUTIC APHERESIS AND DIALYSIS, 2019, 23 (03) : 217 - 223
  • [4] Efficacy of intensive granulocyte-monocyte adsorptive apheresis in patients with ulcerative colitis
    Ishii, Manabu
    Tanaka, Hiroki
    Yamashita, Masaki
    Motoya, Satoshi
    Imamura, Akimichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 134 - 135
  • [5] Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study
    Yamamoto, Takayuki
    Umegae, Satoru
    Matsumoto, Koichi
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (08) : 1003 - 1009
  • [6] Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
    Yokoyama, Yoko
    Kawai, Mikio
    Fukunaga, Ken
    Kamikozuru, Koji
    Nagase, Kazuko
    Nogami, Koji
    Kono, Tomoaki
    Ohda, Yoshio
    Iimuro, Masaki
    Hida, Nobuyuki
    Nakamura, Shiro
    Miwa, Hiroto
    Matsumoto, Takayuki
    BMC GASTROENTEROLOGY, 2013, 13
  • [7] Advantages of Fecal Lactoferrin Measurement during Granulocyte and Monocyte Adsorptive Apheresis Therapy in Ulcerative Colitis
    Hashiguchi, Keiichi
    Takeshima, Fuminao
    Akazawa, Yuko
    Matsushima, Kayoko
    Minami, Hitomi
    Machida, Haruhisa
    Yamaguchi, Naoyuki
    Shiozawa, Ken
    Ohba, Kazuo
    Ohnita, Ken
    Ichikawa, Tatsuki
    Isomoto, Hajime
    Nakao, Kazuhiko
    DIGESTION, 2015, 91 (03) : 208 - 217
  • [8] Is the Benefit of Granulocyte Monocyte Adsorptive Apheresis in Ulcerative Colitis Overstated?
    Sangeetha Thanaraj
    P. John Hamlin
    Alexander C. Ford
    Digestive Diseases and Sciences, 2010, 55 : 1803 - 1804
  • [9] Is the Benefit of Granulocyte Monocyte Adsorptive Apheresis in Ulcerative Colitis Overstated?
    Thanaraj, Sangeetha
    Hamlin, P. John
    Ford, Alexander C.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (06) : 1803 - 1804
  • [10] Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis
    Thanaraj, S.
    Hamlin, P. J.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (11-12) : 1297 - 1306